WuXi Biologics (Cayman) Inc. (HKG:2269)
41.96
-0.04 (-0.10%)
Oct 8, 2025, 2:45 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
1.75M HKD
Profits / Employee
366.33K HKD
Market Cap
170.68B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 12,575 | -165 | -1.30% |
Dec 31, 2023 | 12,740 | 367 | 2.97% |
Dec 31, 2022 | 12,373 | 2,509 | 25.44% |
Dec 31, 2021 | 9,864 | 3,218 | 48.42% |
Dec 31, 2020 | 6,646 | 980 | 17.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines AG | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
Innovent Biologics | 5,659 |
Sino Biopharmaceutical | 24,379 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Akeso | 3,035 |
CSPC Pharmaceutical Group | 21,400 |
WuXi Biologics News
- 12 days ago - WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability - PRNewsWire
- 15 days ago - WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year - PRNewsWire
- 18 days ago - Chinese biotechs get a shot in the arm from policy support, licensing deals - South China Morning Post
- 21 days ago - Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tibbi Cihaz Kurumu (TITCK) - PRNewsWire
- 26 days ago - WuXi Biologics Achieves "CDMO of the Year" Among Three Prestigious IMAPAC Awards - PRNewsWire
- 4 weeks ago - WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry - PRNewsWire
- 5 weeks ago - WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi - PRNewsWire
- 7 weeks ago - WuXi Biologics Reports Solid 2025 Interim Results - PRNewsWire